Heath Lukatch - 08 Apr 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
Heath Lukatch, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
08 Apr 2025
Net transactions value
+$117,490
Form type
4
Filing time
10 Apr 2025, 08:06:33 UTC
Previous filing
10 Jun 2024
Next filing
16 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $96,000 +6,000 +84% $16.00 13,175 08 Apr 2025 Direct
transaction PCVX Common Stock Options Exercise $21,490 +1,000 +7.6% $21.49 14,175 08 Apr 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -6,000 -100% $0.000000 0 08 Apr 2025 Common Stock 6,000 $16.00 Direct F1
transaction PCVX Stock Option (right to buy) Options Exercise $0 -1,000 -6.7% $0.000000 14,000 08 Apr 2025 Common Stock 1,000 $21.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.